ORTEXORTEX News
Tracking ATI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AT
Earnings PreviewATI

ATI Heads Into Q3 Preview With CEO Selling and a Stock That Just Gave Back Ground

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 3 Aug 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

ATI Inc. reports Q3 results on August 6 with the stock down roughly 5% over the past month to $187.44 — a sharp reversal from the year-to-date high that greeted its previous earnings event.

The CEO selling story has continued since the last preview. Kimberly Fields, Chairman and CEO, executed a further $6.1 million sale on July 28 at $190.99 — following the $7.3 million of sales on July 7 documented ahead of the Q2 print. Combined, Fields has sold over $34 million net across the past 90 days. The stock fell 2.7% on the day of the Q2 result itself and has since pulled back from the post-print peak. The CEO's ongoing offload, timed into earnings strength, is the sharpest single signal in the setup. Options and short positioning tell a much quieter story: the put/call ratio is running near its 20-day average at 0.65, barely a third of a standard deviation above the mean, and short interest has eased 4% on the week to 2.8% of the free float. Borrow availability remains vast — shares available to lend exceed 6,700% of current short interest — and cost to borrow is a negligible 0.32%. There is no short-side pressure here.

The analyst community has been consistently constructive, and notably more aggressive in lifting targets after Q2. TD Cowen raised its target from $170 to $210 on July 13, just two weeks before the last print, while Susquehanna moved to $215 and Keybanc to $211 in early-to-mid July. The consensus mean now sits at $200, implying modest upside from current levels. Bulls point to mid-teens projected sales growth in the Specialty Energy segment — nuclear and gas turbine demand — and the 400 basis point EBITDA margin improvement linked to commercial renegotiations. Bears counter that non-aerospace and defense end markets remain under pressure, that the stock's valuation multiple has compressed relative to peers like CRS, and that ex-A&D volumes are not keeping pace with the headline growth story. CRS itself fell nearly 14% on the week, the sharpest drop among close peers, which may reflect sector-wide softness in specialty materials rather than an ATI-specific issue.

The August 6 print will test whether ATI's A&D and specialty energy tailwinds are strong enough to offset continued weakness in medical, industrial, and electronics end markets — and whether management's margin narrative holds up as the revenue mix shifts further toward higher-complexity, lower-volume work.

Stocks in this article

See the live data behind this article on ORTEX.

Open ATI on ORTEX →

How this article was generated

Generated
3 Aug 2026, 04:02
Data as of
3 Aug 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.